企業プロフィール
Nuvation Bio 株価・ニュース・カタリスト
- ティッカー:
- NUVB
- 取引所:
- NYSE
- セクター:
- Biopharma
- 所在地:
- United States
株価パフォーマンス
6.93 USD (+1.46%)
終値
最終更新: 2026年8月21日
1.71B USD
時価総額
株価変動の要因
As of Aug 21, 2026, NUVB closed up 1.46% at $6.93. No new same-company headline was identified in the current news window.
企業概要
事業概要
Nuvation Bio is an oncology company developing targeted cancer therapies and other precision-oncology assets. Its strategy is to build a focused cancer pipeline with broad therapeutic potential.
所在地とセクター分類
Headquartered in the United States and listed on NYSE, Nuvation sits in specialty oncology biotechnology.
ビジネスモデルの特徴
The business depends on clinical data, pipeline selection, and the ability to translate oncology programs into value.
バイオ業界での位置付け
Nuvation is a catalyst-sensitive oncology company whose valuation will depend on clinical and strategic progress.
今後のカタリスト
- Nuvation Bio’s catalysts are taletrectinib and any regulatory or data update in ROS1-positive lung cancer. The market will care about whether the asset can keep building a real oncology franchise.
最近のニュース
類似銘柄
事業成熟度、治療領域、カタリスト傾向が近い同業銘柄です。